Case Report On Ciprofloxacin + Tinidazole Induced Stevens-Johnson Syndrome

Vijaya Sri Sowmya Dhulipudi; Indu Harini S; Sriramulu Naik Banavath

doi:10.67396/jdr.v2i2.58

Authors

Dhulipudi Vijaya Sri Sowmya IV/VI Pharmd, Koringa College of Pharmacy, Korangi-533461, Tallarevu Mandal, Kakinada District, Andhra Pradesh. India.
Indu Harini S Assistant Professor, Koringa College of Pharmacy, Korangi-533461, Tallarevu Mandal, Kakinada District, Andhra Pradesh, India.
Banavath Sriramulu Naik V/VI PharmD, Koringa college of pharmacy, Korangi, Talarevu mandal, Kakinada district, Andhra Pradesh, India.

DOI:

https://doi.org/10.67396/jdr.v2i2.58

Keywords:

Drug reaction, Erythroderma, Fever, Generalized erythema, Dermatological adverse drug reaction, Drug-induced skin eruption

Abstract

A 49 year old Female patient presented to Dermatology department with complaints of redness all over body and fever. Patient was apparently normal when she developed a fever followed by redness starting initially over abdomen followed by Chest, back, upper and lower limbs. Patient has the history of drug taken prior to onset of lesions. Patient has no history of fluid filled lesions, burning mituration, redness of eyes or discharge, genital or oral lesions and No history of previous similar complaints.

Downloads

Download data is not yet available.

References

1. Oakley A, Krishnamurthy K. Stevens-Johnson syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459323/

2. Jha N, Alexander E, Kanish B, Badyal DK. A study of cutaneous adverse drug reactions in a tertiary care centre in Punjab. Indian Dermatol Online J. 2018;9(5):299-303.

3. Auyeung J, Lee M. Successful treatment of Stevens-Johnson syndrome with cyclosporine and corticosteroid. Can J Hosp Pharm. 2018;71(4):272-275.

4. Frey N, Bodmer M, Bircher A, Jick SS, Meier CR, Spoendlin J. Stevens-Johnson syndrome and toxic epidermal necrolysis in association with commonly prescribed drugs in outpatient care other than anti-epileptic drugs and antibiotics: a population-based case-control study. Drug Saf. 2019;42(1):55-66.

5. Sato S, Kanbe T, Tamaki Z, Furuichi M, Uejima Y, Suganuma E, et al. Clinical features of Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatr Int. 2018;60(8):697-702.

6. Yang SC, Hu S, Zhang SZ, Huang JW, Zhang J, Ji C, et al. Corrigendum to “The epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in China”. J Immunol Res. 2018;2018:4154507.

7. Schneider JA, Cohen PR. Stevens-Johnson syndrome and toxic epidermal necrolysis: a concise review with a comprehensive summary of therapeutic interventions emphasizing supportive measures. Adv Ther. 2017;34(6):1235-1244.

8. LeBel M. Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy. 1988;8(1):3-33.

9. Brunton LL, Hilal-Dandan R, Knollmann BC, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 13th ed. New York: McGraw-Hill Education; 2018. p. 1057-1060.